Imricor Medical Systems Inc (ASX: IMR) Share Price and News





  (20 mins delayed)

52 Week Range


1 Year Return


Imricor Medical Systems Inc Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $93.17 million
P/E Ratio N/A
Dividend Yield 0.00%
Shares Outstanding 202.55 million
Earnings per share -0.136
Dividend per share N/A
Year To Date Return -16.67%
Earnings Yield N/A
Franking -
Share Price

Day Change

52 Week Range


Yesterday's Close

Today's Open

Days Range



Avg. Volume (1 month)


as at 24 Feb 3:44pm

  • Imricor Medical Systems Inc (ASX: IMR)
    Latest News

    Doctor looking serious with arms crossed
    Healthcare Shares

    Here's why the Imricor Medical (ASX:IMR) share price is surging 8% today

    What did the company update the ASX with?

    Read more »

    male wearing face mask reviewing medical scans on light box
    Healthcare Shares

    Imricor Medical (ASX:IMR) share price spikes 6% after expanding trial sites

    The vascular catheter specialist share price having a great Friday.

    Read more »

    share price up
    Share Market News

    Why the Imricor (ASX:IMR) share price is racing 6% higher today

    The company is pushing ahead with its strategy...

    Read more »

    Young doctor raising arms in air with hands in fists celebrating a new development
    Healthcare Shares

    Imricor (ASX:IMR) share price rises on latest update

    The Imricor Medical Systems Inc (ASX: IMR) share price is edging higher today after news another hospital has purchased one…

    Read more »

    medical asx share price represented by doctor giving thumbs up
    Share Market News

    Why the Imricor (ASX:IMR) share price is edging higher today

    The Imricor Medical Systems Inc. (ASX: IMR) share price is edging higher today following two major announcements.

    Read more »

    IMR ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size

    About Imricor Medical Systems Inc

    Imricor Medical Systems Inc is a medical device company engaged in addressing issues with traditional x-ray-guided ablation procedures through the development of MRI-guided technology. Its principal business activities are to design, manufacture and sell MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. The products of the company include Advantage-MR EP Recorder/Stimulator, Vision-MR Ablation Catheter and Vision-MR Dispersive Electrode.

    IMR Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    17 May 2024 $0.46 $0.01 2.22% 170,332 $0.45 $0.46 $0.44
    16 May 2024 $0.45 $-0.01 -2.20% 295,183 $0.46 $0.46 $0.44
    14 May 2024 $0.46 $0.00 0.00% 219,025 $0.50 $0.50 $0.46
    13 May 2024 $0.46 $0.00 0.00% 137,925 $0.48 $0.48 $0.46
    10 May 2024 $0.46 $0.00 0.00% 122,294 $0.48 $0.49 $0.46
    09 May 2024 $0.46 $-0.03 -6.25% 254,196 $0.49 $0.49 $0.46
    08 May 2024 $0.48 $-0.02 -4.04% 25,217 $0.50 $0.50 $0.48
    07 May 2024 $0.50 $0.01 2.04% 47,559 $0.49 $0.50 $0.47
    06 May 2024 $0.49 $0.02 4.26% 231,145 $0.48 $0.50 $0.48
    03 May 2024 $0.47 $-0.01 -2.11% 51,216 $0.49 $0.49 $0.47
    02 May 2024 $0.48 $0.01 2.13% 55,854 $0.48 $0.48 $0.47
    01 May 2024 $0.47 $-0.03 -6.06% 61,770 $0.50 $0.50 $0.47
    30 Apr 2024 $0.50 $0.01 2.04% 89,290 $0.50 $0.52 $0.49
    29 Apr 2024 $0.49 $0.00 0.00% 5,000 $0.49 $0.49 $0.49
    26 Apr 2024 $0.49 $-0.01 -2.00% 55,367 $0.50 $0.50 $0.48
    24 Apr 2024 $0.50 $0.02 4.17% 61,146 $0.50 $0.51 $0.50
    23 Apr 2024 $0.48 $-0.04 -7.69% 27,606 $0.51 $0.51 $0.48
    22 Apr 2024 $0.52 $0.01 1.94% 33,555 $0.52 $0.52 $0.52
    19 Apr 2024 $0.52 $0.01 1.98% 83,724 $0.51 $0.52 $0.50

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    07 May 2024 Peter McGregor Buy 100,000 $48,368
    On-market trade.
    28 Feb 2024 Peter McGregor Issued 78,271 $35,221
    Rights issue. 665,479 CDIs , as per announcement on 01-03-2024
    02 Jun 2023 Steve Wedan Issued 1,426,949 $456,623
    Issue of options.
    02 Jun 2023 Steve Wedan Expiry 173,756 $55,601
    Options expired.
    19 May 2023 Mark Tibbles Issued 179,775 $47,640
    Issue of securities. CDIs
    19 May 2023 Anita Messal Issued 168,539 $44,662
    Issue of securities. CDIs
    19 May 2023 Peter McGregor Issued 179,775 $47,640
    Issue of securities. 587,028 CDIs

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Peter McGregor Non-Executive Director May 2019
    Mr McGregor has over 30 years' experience in senior finance and management roles, including having been a partner in the investment banking firm of Goldman Sachs JBWere and a managing director in the institutional banking & markets division of Commonwealth Bank of Australia. He is also a former Chief Financial Officer of the ASX50 transport company, Asciano Limited , and Chief Operating Officer of ASX listed Australian Infrastructure Fund Limited. He currently serves as a director of Pivotal Systems Corporation, True Infrastructure Management Pty Ltd and Chain Collective Pty Ltd. He holds a Bachelor of Commerce from the University of Melbourne, is a member of the Australian Institute of Company Directors and a Fellow of the Financial Services Institute of Australasia.

    Mr Steve Wedan Chief Executive OfficerPresidentExecutive ChairmanExecutive Director May 2006
    Mr Wedan co-founded the Company in 2006 and has served as CEO since that time. He is responsible for the overall management and strategic direction of the Company. He has over 30 years of experience in the medical device industry including design engineering of MRI and ultrasound systems for GE Healthcare, as well as Vice President and Chief Technology Officer for Applied Biometrics Inc. Immediately prior to co-founding Imricor, He founded and operated a technical consulting company, Wedan Technologies Inc., from 2000-2006.He is a member of various international standards committees in the fields of MRI safety and the compatibility of implanted and interventional products in MRI. He currently serves on the Board of Directors of Medical Device Research Forum, Inc. and Water Rescue Innovations, Inc., as well as the Advisory Board of Poiesis Medical, LLC.He holds a Bachelor of Science in Electrical Engineering from Michigan Technological University, and a Master of Science in Electrical Engineering from Marquette University.

    Mr Mark Tibbles Non-Executive Deputy ChairmanNon-Executive Director Sep 2014
    Mr Tibbles is an entrepreneur, business owner, company director and active venture investor in and advisor to technology, life science and medical device companies. He is currently a Board member of, Inc. and Operandi, Inc.; Poiesis Medical LLC's Chief Strategy Officer and Executive Committee Member; an owner and managing member of STEM Fuse, LLC and the Managing Director of Strategic Stage Ventures, LLC. Prior to his current roles, He was a Board member of the Nerdery, LLC as well as an owner and member of Intuitive Technology Group until it was sold in 2017.He was also a President and founder of PRC Consulting, Inc, from 1998 until 2013.He holds a Bachelor of Arts from Oral Roberts University.

    Ms Anita Messal Non-Executive Director Mar 2021
    Ms. Messal has over 35 years of experience in the health care and benefits industry, most recently as the Chief Integration Officer at AccentCare. She has experience in health plan services, health care delivery, care management, and benefits administration. She has worked with self-funded, fully insured and CMS funded care. Her customers and partners include large and mid-size employers, health plans, insurance carriers, brokers, resellers, enterprise software companies and consumers. She has participated in fund raising from start-up through IPO and sale to strategic buyers and private equity. She has worked in both F100 and start-up companies with experience in public, private and non-profit businesses. Her experience includes working in domestic and international markets, with time spent developing programs and partnerships in the United Kingdom and Europe.

    Mr Kobe Li Company Secretary
    Kobe Li Company Secretary

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Citicorp Nominees Pty Limited 19,376,860 12.80%
    HSBC Custody Nominees (Australia) Limited(i) 12,151,749 8.03%
    BNP Paribas Nominees Pty Ltd 8,870,165 5.86%
    Siemens Medical Solutions Usa Inc 8,384,150 5.54%
    Warren G Herreid Ii 7,819,431 5.12%
    BNP Paribas Noms(Nz) Ltd 6,373,066 4.21%
    HSBC Custody Nominees (Australia) Limited(ii) 3,365,707 2.22%
    Kahr Foundation 2,950,988 1.95%
    Steven R Wedan 2,693,720 1.78%
    Bauer Private Equity Fund Vi Llc 1,696,555 1.12%
    Steven R Wedan & Cherri J Wedan Jt Ten 1,427,373 0.94%
    Merrill Lynch (Australia) Nominees Pty Limited 1,393,726 0.92%
    Ronald D Berger 1,300,000 0.86%
    Pacific Premier Trust Cust Fbo Jeffrey J Quinn Ira 1,288,462 0.85%
    Bradica Nominees Pty Ltd 1,160,421 0.77%
    All States Secretariat Pty Limited 1,000,000 0.66%
    Trust Company Cust Fbo Kristin Knight Ira 961,538 0.64%
    Bnp Paribas Noms Pty Ltd 928,581 0.61%
    Fleitman Koppa Investments Llc 901,530 0.60%
    Shear Family Group Pty Ltd 874,123 0.58%